(Q34447633)

2 August 2017

Debrisoquine oxidation in an Australian population (English)

1 reference

2 August 2017

Peart GF

1

1 reference

2 August 2017

Boutagy J

series ordinal

2

1 reference

2 August 2017

Shenfield GM

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 1986

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

21

1 reference

2 August 2017

5

1 reference

2 August 2017

465-471

1 reference

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401023

A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401023

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401023

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401023

Assessment of the drug metabolism capacity of the liver

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401023

An improved and simplified method of detecting the acetylator phenotype

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401023

Polymorphic hydroxylation of Debrisoquine in man.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401023

The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02827.X

Debrisoquine hydroxylation capacity: problems of assessment in two populations

21 January 2018

1 reference

12 December 2020

Screening methods using sulfamethazine for determining acetylator phenotype

1 reference

12 December 2020

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

1 reference

12 December 2020

Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection

1 reference

12 December 2020

Genetically determined variability in drug metabolism: dual slow acetylation and drug oxidation traits

1 reference

12 December 2020

10.1111/J.1365-2125.1986.TB02827.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference